The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Incyte
Research Funding - AbbVie; GlaxoSmithKline; Janssen; Millennium; Novartis; Pfizer
Expert Testimony - AbbVie
Travel, Accommodations, Expenses - Incyte

Assessing the prognostic impact of intermediate outcomes on survival time in relapsed/refractory multiple myeloma (RRMM) patients (pts) via a robust and clinically interpretable quantitative procedure.
 
Rajeev Ayyagari
Research Funding - AbbVie; GlaxoSmithKline; Millennium; Novartis; Pfizer
 
Wendy Y Cheng
Research Funding - GlaxoSmithKline; Janssen; Lundbeck; Millennium; Novartis; Pfizer
 
Xiaopeng Cai
Research Funding - Millennium
 
Casey Jones
Research Funding - GlaxoSmithKline; Millennium; Novartis; Purdue Pharma
 
Esprit Ma
Employment - Millennium
 
Vijayveer Bonthapally
Employment - Millennium
 
Yanyan Zhu
Employment - Millennium
 
Patrick Lefebvre
Research Funding - Millennium
 
L J Wei
Expert Testimony - Pfizer
 
Mei Sheng Duh
No Relationships to Disclose